Paul Veys Selected Research

Paul Veys Research Topics

Disease

23	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 02/2003
19	Infections 10/2022 - 02/2004
12	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022 - 09/2010
12	Primary Immunodeficiency Diseases 12/2021 - 02/2010
8	Virus Diseases (Viral Diseases) 01/2020 - 09/2006
6	Wiskott-Aldrich Syndrome 01/2022 - 01/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 06/2012
6	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2020 - 02/2006
5	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2022 - 08/2011
4	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 06/2007
4	Aplastic Anemia (Anemia, Hypoplastic) 09/2020 - 05/2012
4	Chronic Granulomatous Disease 01/2020 - 01/2011
4	Neoplasms (Cancer) 01/2020 - 12/2009
4	Viremia 01/2018 - 09/2007
4	Mucopolysaccharidosis I (Hurler Syndrome) 11/2017 - 05/2013
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 06/2012
2	Immune System Diseases (Immune Disorders) 01/2022 - 03/2009
2	Hemorrhage 12/2021 - 02/2013
2	Bronchiolitis Obliterans Syndrome 01/2021 - 01/2019
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 12/2020 - 11/2013
2	Shwachman-Diamond Syndrome 09/2020 - 01/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 01/2002
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2018 - 11/2009
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018 - 02/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2017 - 06/2007
2	Lymphopenia (Lymphocytopenia) 01/2017 - 01/2016
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 11/2016 - 09/2012
2	Pulmonary Hypertension 03/2013 - 03/2008
2	Pneumonia (Pneumonitis) 02/2004 - 05/2003
1	Leukocyte adhesion deficiency type 1 12/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Job Syndrome (Hyper-IgE Syndrome) 01/2021
1	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 10/2020
1	Human Influenza (Influenza) 10/2020
1	Thrombotic Microangiopathies 01/2020
1	Neutropenia 01/2020
1	Body Weight (Weight, Body) 12/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Coinfection 01/2019
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 01/2019
1	Infertility (Sterility) 01/2019
1	Sclerosing Cholangitis 01/2019
1	Cytokine Release Syndrome 01/2019
1	Arthritis (Polyarthritis) 10/2018
1	Respiratory Insufficiency (Respiratory Failure) 10/2018
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 10/2018
1	Macrophage Activation Syndrome 10/2018
1	Diarrhea 01/2017
1	Colitis 01/2017
1	Colic (Abdominal Cramps) 01/2017
1	Reticular dysgenesis 01/2017
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 01/2017
1	Food Hypersensitivity (Food Allergy) 01/2016
1	Eosinophilia 01/2016
1	Eczema 01/2016
1	Leukemia 01/2016

Drug/Important Bio-Agent (IBA)

7	Busulfan (Busulfex)FDA Link 12/2020 - 04/2011
6	Alemtuzumab (Campath)FDA Link 01/2021 - 06/2011
5	treosulfanIBA 01/2020 - 04/2011
4	Adenosine DeaminaseIBA 01/2022 - 08/2011
4	Antiviral Agents (Antivirals)IBA 01/2019 - 08/2005
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2009
3	Chimeric Antigen ReceptorsIBA 10/2021 - 10/2018
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 10/2005
3	EnzymesIBA 11/2016 - 08/2011
2	defibrotideIBA 12/2020 - 11/2013
2	Pharmaceutical PreparationsIBA 01/2020 - 10/2018
2	AntigensIBA 01/2020 - 01/2013
2	CD40 Ligand (CD40L)IBA 01/2019 - 02/2004
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 10/2005
2	fludarabineIBA 10/2016 - 04/2011
2	Melphalan (Alkeran)FDA LinkGeneric 10/2016 - 04/2011
2	purineIBA 10/2012 - 08/2011
2	SteroidsIBA 03/2012 - 06/2009
1	Transcription Factor 3IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Zanamivir (Relenza)FDA Link 10/2020
1	favipiravirIBA 10/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	NucleotidesIBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Antirheumatic Agents (DMARD)IBA 10/2018
1	Rheumatoid FactorIBA 10/2018
1	Oxygen (Dioxygen)IBA 10/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	Cidofovir (Vistide)FDA Link 01/2017
1	brincidofovirIBA 01/2017
1	Immunoglobulin E (IgE)IBA 01/2016
1	CytokinesIBA 01/2016

Therapy/Procedure

39	Transplantation 10/2022 - 02/2003
34	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2008
24	Stem Cell Transplantation 01/2020 - 01/2002
14	Cell Transplantation 01/2022 - 08/2011
12	Therapeutics 01/2020 - 08/2005
6	Drug Therapy (Chemotherapy) 01/2020 - 01/2011
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 06/2007
2	Immunotherapy 01/2020 - 01/2010
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 12/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Noninvasive Ventilation 10/2018